HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dasharatha G Reddy Selected Research

RP5063

5/2018Evaluation of the effects of RP5063, a novel, multimodal, serotonin receptor modulator, as single-agent therapy and co-administrated with sildenafil, bosentan, and treprostinil in a monocrotaline-induced pulmonary arterial hypertension rat model.
9/2017RP5063, a novel, multimodal, serotonin receptor modulator, prevents monocrotaline-induced pulmonary arterial hypertension in rats.
9/2017RP5063, a novel, multimodal, serotonin receptor modulator, prevents Sugen 5416-hypoxia-induced pulmonary arterial hypertension in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dasharatha G Reddy Research Topics

Disease

3Pulmonary Arterial Hypertension
05/2018 - 09/2017
1Hypertrophy
09/2017

Drug/Important Bio-Agent (IBA)

3RP5063IBA
05/2018 - 09/2017
3Serotonin (5 Hydroxytryptamine)IBA
05/2018 - 09/2017
3Serotonin ReceptorsIBA
05/2018 - 09/2017
2MonocrotalineIBA
05/2018 - 09/2017
2Dopamine (Intropin)FDA LinkGeneric
05/2018 - 09/2017
1Bosentan (Tracleer)FDA Link
05/2018
1Sildenafil Citrate (Viagra)FDA Link
05/2018
1treprostinilFDA Link
05/2018

Therapy/Procedure

1Therapeutics
05/2018